Phase II study of adjuvant nab-paclitaxel plus S-1 after D2 resection in stage III diffuse gastric cancer (NORDICA study). This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results